請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/6102
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳佩燁 | |
dc.contributor.author | Chi-Chen Chuang | en |
dc.contributor.author | 莊琦珍 | zh_TW |
dc.date.accessioned | 2021-05-16T16:20:56Z | - |
dc.date.available | 2018-08-22 | |
dc.date.available | 2021-05-16T16:20:56Z | - |
dc.date.copyright | 2013-08-22 | |
dc.date.issued | 2013 | |
dc.date.submitted | 2013-08-01 | |
dc.identifier.citation | Dobson, C. M. (2004). Principles of protein folding, misfolding and
aggregation. Semin Cell Dev Biol 15, 3-16. 2. Wolynes, P. G., Onuchic, J. N. & Thirumalai, D. (1995). Navigating the folding routes. Science 267, 1619-20. 3. Dill, K. A. & Chan, H. S. (1997). From Levinthal to pathways to funnels. Nat Struct Biol 4, 10-9. 4. Jahn, T. R. & Radford, S. E. (2005). The Yin and Yang of protein folding. FEBS J 272, 5962-70. 5. Rochet, J. C. & Lansbury, P. T., Jr. (2000). Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol 10, 60-8. 6. Stefani, M. & Dobson, C. M. (2003). Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med (Berl) 81, 678-99. 7. Hartl, F. U., Bracher, A. & Hayer-Hartl, M. (2011). Molecular chaperones in protein folding and proteostasis. Nature 475, 324-32. 8. Cobb, N. J. & Surewicz, W. K. (2009). Prion diseases and their biochemical mechanisms. Biochemistry 48, 2574-85. 9. Prusiner, S. B. (1998). Prions. Proc Natl Acad Sci U S A 95, 13363-83. 10. Collinge, J. (2001). Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24, 519-50. 11. Imran, M. & Mahmood, S. (2011). An overview of animal prion diseases. Virol J 8, 493. 12. Will, R. G., Ironside, J. W., Zeidler, M., Cousens, S. N., Estibeiro, K., Alperovitch, A., Poser, S., Pocchiari, M., Hofman, A. & Smith, P. G. (1996). A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921-5. 13. Trevitt, C. R. & Singh, P. N. (2003). Variant Creutzfeldt-Jakob disease: pathology, epidemiology, and public health implications. Am J Clin Nutr 78, 651S-656S. 14. Beghi, E., Gandolfo, C., Ferrarese, C., Rizzuto, N., Poli, G., Tonini, M. C., Vita, G., Leone, M., Logroscino, G., Granieri, E., Salemi, G., Savettieri, G., Frattola, L., Ru, G., Mancardi, G. L. & Messina, C. (2004). Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases. Neurol Sci 25, 122-9. 87 15. Baeten, L. A., Powers, B. E., Jewell, J. E., Spraker, T. R. & Miller, M. W. (2007). A natural case of chronic wasting disease in a free-ranging moose (Alces alces shirasi). J Wildl Dis 43, 309-14. 16. Joly, D. O., Samuel, M. D., Langenberg, J. A., Rolley, R. E. & Keane, D. P. (2009). Surveillance to detect chronic wasting disease in white-tailed deer in Wisconsin. J Wildl Dis 45, 989-97. 17. Walsh, D. P. & Miller, M. W. (2010). A weighted surveillance approach for detecting chronic wasting disease foci. J Wildl Dis 46, 118-35. 18. Sigurdson, C. J. (2008). A prion disease of cervids: chronic wasting disease. Vet Res 39, 41. 19. Williams, E. S. (2005). Chronic wasting disease. Vet Pathol 42, 530-49. 20. Miller, M. W., Williams, E. S., Hobbs, N. T. & Wolfe, L. L. (2004). Environmental sources of prion transmission in mule deer. Emerg Infect Dis 10, 1003-6. 21. Gilch, S., Chitoor, N., Taguchi, Y., Stuart, M., Jewell, J. E. & Schatzl, H. M. (2011). Chronic wasting disease. Top Curr Chem 305, 51-77. 22. Bolton, D. C., McKinley, M. P. & Prusiner, S. B. (1982). Identification of a protein that purifies with the scrapie prion. Science 218, 1309-11. 23. Alper, T., Cramp, W. A., Haig, D. A. & Clarke, M. C. (1967). Does the agent of scrapie replicate without nucleic acid? Nature 214, 764-6. 24. Rogers, N. G., Basnight, M., Gibbs, C. J. & Gajdusek, D. C. (1967). Latent viruses in chimpanzees with experimental kuru. Nature 216, 446-9. 25. Griffith, J. S. (1967). Self-replication and scrapie. Nature 215, 1043-4. 26. Prusiner, S. B., Bolton, D. C., Groth, D. F., Bowman, K. A., Cochran, S. P. & McKinley, M. P. (1982). Further purification and characterization of scrapie prions. Biochemistry 21, 6942-50. 27. Gabizon, R., McKinley, M. P., Groth, D. & Prusiner, S. B. (1988). Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc Natl Acad Sci U S A 85, 6617-21. 28. Oesch, B., Westaway, D., Walchli, M., McKinley, M. P., Kent, S. B., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E. & et al. (1985). A cellular gene encodes scrapie PrP 27-30 protein. Cell 40, 735-46. 29. Hsiao, K. K., Scott, M., Foster, D., Groth, D. F., DeArmond, S. J. & Prusiner, S. B. (1990). Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250, 1587-90. 30. Bueler, H., Aguzzi, A., Sailer, A., Greiner, R. A., Autenried, P., Aguet, M. & Weissmann, C. (1993). Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-47. 88 31. Stahl, N., Borchelt, D. R., Hsiao, K. & Prusiner, S. B. (1987). Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51, 229-40. 32. Kretzschmar, H. A., Stowring, L. E., Westaway, D., Stubblebine, W. H., Prusiner, S. B. & Dearmond, S. J. (1986). Molecular cloning of a human prion protein cDNA. DNA 5, 315-24. 33. Aguzzi, A. & Polymenidou, M. (2004). Mammalian prion biology: one century of evolving concepts. Cell 116, 313-27. 34. Kretzschmar, H. A., Prusiner, S. B., Stowring, L. E. & DeArmond, S. J. (1986). Scrapie prion proteins are synthesized in neurons. Am J Pathol 122, 1-5. 35. Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R. & Wuthrich, K. (1996). NMR structure of the mouse prion protein domain PrP(121-231). Nature 382, 180-2. 36. Donne, D. G., Viles, J. H., Groth, D., Mehlhorn, I., James, T. L., Cohen, F. E., Prusiner, S. B., Wright, P. E. & Dyson, H. J. (1997). Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci U S A 94, 13452-7. 37. Riek, R., Hornemann, S., Wider, G., Glockshuber, R. & Wuthrich, K. (1997). NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett 413, 282-8. 38. Zahn, R., Liu, A., Luhrs, T., Riek, R., von Schroetter, C., Lopez Garcia, F., Billeter, M., Calzolai, L., Wider, G. & Wuthrich, K. (2000). NMR solution structure of the human prion protein. Proc Natl Acad Sci U S A 97, 145-50. 39. Pan, K. M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., Mehlhorn, I., Huang, Z., Fletterick, R. J., Cohen, F. E. & et al. (1993). Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 90, 10962-6. 40. Anfinsen, C. B. (1973). Principles that govern the folding of protein chains. Science 181, 223-30. 41. McKinley, M. P., Bolton, D. C. & Prusiner, S. B. (1983). A protease-resistant protein is a structural component of the scrapie prion. Cell 35, 57-62. 42. Surewicz, W. K. & Apostol, M. I. (2011). Prion protein and its conformational conversion: a structural perspective. Top Curr Chem 305, 135-67. 43. Jarrett, J. T. & Lansbury, P. T., Jr. (1993). Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-8. 89 44. Aguzzi, A. & Sigurdson, C. J. (2004). Antiprion immunotherapy: to suppress or to stimulate? Nat Rev Immunol 4, 725-36. 45. Harper, J. D. & Lansbury, P. T., Jr. (1997). Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66, 385-407. 46. Rogers, M., Yehiely, F., Scott, M. & Prusiner, S. B. (1993). Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells. Proc Natl Acad Sci U S A 90, 3182-6. 47. Supattapone, S., Bosque, P., Muramoto, T., Wille, H., Aagaard, C., Peretz, D., Nguyen, H. O., Heinrich, C., Torchia, M., Safar, J., Cohen, F. E., DeArmond, S. J., Prusiner, S. B. & Scott, M. (1999). Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice. Cell 96, 869-78. 48. Holscher, C., Delius, H. & Burkle, A. (1998). Overexpression of nonconvertible PrPc delta114-121 in scrapie-infected mouse neuroblastoma cells leads to trans-dominant inhibition of wild-type PrP(Sc) accumulation. J Virol 72, 1153-9. 49. Forloni, G., Angeretti, N., Chiesa, R., Monzani, E., Salmona, M., Bugiani, O. & Tagliavini, F. (1993). Neurotoxicity of a prion protein fragment. Nature 362, 543-6. 50. Chabry, J., Caughey, B. & Chesebro, B. (1998). Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides. J Biol Chem 273, 13203-7. 51. Nguyen, J., Baldwin, M. A., Cohen, F. E. & Prusiner, S. B. (1995). Prion protein peptides induce alpha-helix to beta-sheet conformational transitions. Biochemistry 34, 4186-92. 52. Kaneko, K., Peretz, D., Pan, K. M., Blochberger, T. C., Wille, H., Gabizon, R., Griffith, O. H., Cohen, F. E., Baldwin, M. A. & Prusiner, S. B. (1995). Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform. Proc Natl Acad Sci U S A 92, 11160-4. 53. Huang, Z., Gabriel, J. M., Baldwin, M. A., Fletterick, R. J., Prusiner, S. B. & Cohen, F. E. (1994). Proposed three-dimensional structure for the cellular prion protein. Proc Natl Acad Sci U S A 91, 7139-43. 54. Zhang, H., Kaneko, K., Nguyen, J. T., Livshits, T. L., Baldwin, M. A., Cohen, F. E., James, T. L. & Prusiner, S. B. (1995). Conformational transitions in peptides containing two putative alpha-helices of the prion protein. J Mol Biol 250, 514-26. 90 55. Blondelle, S. E., Forood, B., Houghten, R. A. & Perez-Paya, E. (1997). Polyalanine-based peptides as models for self-associated beta-pleated-sheet complexes. Biochemistry 36, 8393-400. 56. Huang, Z., Prusiner, S. B. & Cohen, F. E. (1996). Structures of prion proteins and conformational models for prion diseases. Curr Top Microbiol Immunol 207, 49-67. 57. Alpers, M. & Gajdusek, D. C. (1965). Changing patterns of kuru: epidemiological changes in the period of increasing contact of the Fore people with western civilization. Am J Trop Med Hyg 14, 852-79. 58. Kocisko, D. A., Come, J. H., Priola, S. A., Chesebro, B., Raymond, G. J., Lansbury, P. T. & Caughey, B. (1994). Cell-free formation of protease-resistant prion protein. Nature 370, 471-4. 59. Bruce, M. E., Will, R. G., Ironside, J. W., McConnell, I., Drummond, D., Suttie, A., McCardle, L., Chree, A., Hope, J., Birkett, C., Cousens, S., Fraser, H. & Bostock, C. J. (1997). Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389, 498-501. 60. Aguzzi, A., Heikenwalder, M. & Polymenidou, M. (2007). Insights into prion strains and neurotoxicity. Nat Rev Mol Cell Biol 8, 552-61. 61. Schatzl, H. M., Da Costa, M., Taylor, L., Cohen, F. E. & Prusiner, S. B. (1995). Prion protein gene variation among primates. J Mol Biol 245, 362-74. 62. Scott, M., Foster, D., Mirenda, C., Serban, D., Coufal, F., Walchli, M., Torchia, M., Groth, D., Carlson, G., DeArmond, S. J., Westaway, D. & Prusiner, S. B. (1989). Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59, 847-57. 63. McKintosh, E., Tabrizi, S. J. & Collinge, J. (2003). Prion diseases. J Neurovirol 9, 183-93. 64. Priola, S. A., Caughey, B., Wehrly, K. & Chesebro, B. (1995). A 60-kDa prion protein (PrP) with properties of both the normal and scrapie-associated forms of PrP. J Biol Chem 270, 3299-305. 65. Scott, M. R., Kohler, R., Foster, D. & Prusiner, S. B. (1992). Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci 1, 986-97. 66. Scott, M., Groth, D., Foster, D., Torchia, M., Yang, S. L., DeArmond, S. J. & Prusiner, S. B. (1993). Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell 73, 979-88. 67. Raymond, G. J., Bossers, A., Raymond, L. D., O'Rourke, K. I., McHolland, 91 L. E., Bryant, P. K., 3rd, Miller, M. W., Williams, E. S., Smits, M. & Caughey, B. (2000). Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease. EMBO J 19, 4425-30. 68. Raymond, G. J., Hope, J., Kocisko, D. A., Priola, S. A., Raymond, L. D., Bossers, A., Ironside, J., Will, R. G., Chen, S. G., Petersen, R. B., Gambetti, P., Rubenstein, R., Smits, M. A., Lansbury, P. T., Jr. & Caughey, B. (1997). Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature 388, 285-8. 69. Lee, L. Y. & Chen, R. P. (2007). Quantifying the sequence-dependent species barrier between hamster and mouse prions. J Am Chem Soc 129, 1644-52. 70. Kocisko, D. A., Priola, S. A., Raymond, G. J., Chesebro, B., Lansbury, P. T., Jr. & Caughey, B. (1995). Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proc Natl Acad Sci U S A 92, 3923-7. 71. Goldmann, W., Martin, T., Foster, J., Hughes, S., Smith, G., Hughes, K., Dawson, M. & Hunter, N. (1996). Novel polymorphisms in the caprine PrP gene: a codon 142 mutation associated with scrapie incubation period. J Gen Virol 77 ( Pt 11), 2885-91. 72. Priola, S. A. (1999). Prion protein and species barriers in the transmissible spongiform encephalopathies. Biomed Pharmacother 53, 27-33. 73. Horiuchi, M. & Caughey, B. (1999). Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J 18, 3193-203. 74. Chernoff, Y. O. (2004). Do amyloids remember their origin? New insights into the prion species barrier. Mol Cell 14, 147-8. 75. Vanik, D. L., Surewicz, K. A. & Surewicz, W. K. (2004). Molecular basis of barriers for interspecies transmissibility of mammalian prions. Mol Cell 14, 139-45. 76. Tahiri-Alaoui, A. & James, W. (2005). Rapid formation of amyloid from alpha-monomeric recombinant human PrP in vitro. Protein Sci 14, 942-7. 77. Asano, M., Mohri, S., Ironside, J. W., Ito, M., Tamaoki, N. & Kitamoto, T. (2006). vCJD prion acquires altered virulence through trans-species infection. Biochem Biophys Res Commun 342, 293-9. 78. Scott, M. R., Safar, J., Telling, G., Nguyen, O., Groth, D., Torchia, M., Koehler, R., Tremblay, P., Walther, D., Cohen, F. E., DeArmond, S. J. & 92 Prusiner, S. B. (1997). Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice. Proc Natl Acad Sci U S A 94, 14279-84. 79. Collinge, J., Sidle, K. C., Meads, J., Ironside, J. & Hill, A. F. (1996). Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383, 685-90. 80. Shibuya, S., Higuchi, J., Shin, R. W., Tateishi, J. & Kitamoto, T. (1998). Protective prion protein polymorphisms against sporadic Creutzfeldt-Jakob disease. Lancet 351, 419. 81. Palmer, M. S., Dryden, A. J., Hughes, J. T. & Collinge, J. (1991). Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352, 340-2. 82. Mead, S., Stumpf, M. P., Whitfield, J., Beck, J. A., Poulter, M., Campbell, T., Uphill, J. B., Goldstein, D., Alpers, M., Fisher, E. M. & Collinge, J. (2003). Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300, 640-3. 83. Liu, H., Farr-Jones, S., Ulyanov, N. B., Llinas, M., Marqusee, S., Groth, D., Cohen, F. E., Prusiner, S. B. & James, T. L. (1999). Solution structure of Syrian hamster prion protein rPrP(90-231). Biochemistry 38, 5362-77. 84. Angers, R. C., Browning, S. R., Seward, T. S., Sigurdson, C. J., Miller, M. W., Hoover, E. A. & Telling, G. C. (2006). Prions in skeletal muscles of deer with chronic wasting disease. Science 311, 1117. 85. Mawhinney, S., Pape, W. J., Forster, J. E., Anderson, C. A., Bosque, P. & Miller, M. W. (2006). Human prion disease and relative risk associated with chronic wasting disease. Emerg Infect Dis 12, 1527-35. 86. Belay, E. D., Maddox, R. A., Williams, E. S., Miller, M. W., Gambetti, P. & Schonberger, L. B. (2004). Chronic wasting disease and potential transmission to humans. Emerg Infect Dis 10, 977-84. 87. Bruce, M. E., McBride, P. A. & Farquhar, C. F. (1989). Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie. Neurosci Lett 102, 1-6. 88. Xie, Z., O'Rourke, K. I., Dong, Z., Jenny, A. L., Langenberg, J. A., Belay, E. D., Schonberger, L. B., Petersen, R. B., Zou, W., Kong, Q., Gambetti, P. & Chen, S. G. (2006). Chronic wasting disease of elk and deer and Creutzfeldt-Jakob disease: comparative analysis of the scrapie prion protein. J Biol Chem 281, 4199-206. 89. Bartz, J. C., Marsh, R. F., McKenzie, D. I. & Aiken, J. M. (1998). The host range of chronic wasting disease is altered on passage in ferrets. Virology 93 251, 297-301. 90. Bartz, J. C., Bessen, R. A., McKenzie, D., Marsh, R. F. & Aiken, J. M. (2000). Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy. J Virol 74, 5542-7. 91. Bellworthy, S. J., Hawkins, S. A., Green, R. B., Blamire, I., Dexter, G., Dexter, I., Lockey, R., Jeffrey, M., Ryder, S., Berthelin-Baker, C. & Simmons, M. M. (2005). Tissue distribution of bovine spongiform encephalopathy infectivity in Romney sheep up to the onset of clinical disease after oral challenge. Vet Rec 156, 197-202. 92. O'Rourke, K. I., Besser, T. E., Miller, M. W., Cline, T. F., Spraker, T. R., Jenny, A. L., Wild, M. A., Zebarth, G. L. & Williams, E. S. (1999). PrP genotypes of captive and free-ranging Rocky Mountain elk (Cervus elaphus nelsoni) with chronic wasting disease. J Gen Virol 80 ( Pt 10), 2765-9. 93. Kong, Q., Huang, S., Zou, W., Vanegas, D., Wang, M., Wu, D., Yuan, J., Zheng, M., Bai, H., Deng, H., Chen, K., Jenny, A. L., O'Rourke, K., Belay, E. D., Schonberger, L. B., Petersen, R. B., Sy, M. S., Chen, S. G. & Gambetti, P. (2005). Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci 25, 7944-9. 94. Tamguney, G., Giles, K., Bouzamondo-Bernstein, E., Bosque, P. J., Miller, M. W., Safar, J., DeArmond, S. J. & Prusiner, S. B. (2006). Transmission of elk and deer prions to transgenic mice. J Virol 80, 9104-14. 95. Marsh, R. F., Kincaid, A. E., Bessen, R. A. & Bartz, J. C. (2005). Interspecies transmission of chronic wasting disease prions to squirrel monkeys (Saimiri sciureus). J Virol 79, 13794-6. 96. Ventura, S., Lacroix, E. & Serrano, L. (2002). Insights into the origin of the tendency of the PI3-SH3 domain to form amyloid fibrils. J Mol Biol 322, 1147-58. 97. Bessen, R. A. & Marsh, R. F. (1994). Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68, 7859-68. 98. Aldhous, P. (1990). BSE: spongiform encephalopathy found in cat. Nature 345, 194. 99. Gibbs, C. J., Jr. & Gajdusek, D. C. (1973). Experimental subacute spongiform virus encephalopathies in primates and other laboratory animals. Science 182, 67-8. 100. Kaneko, K., Zulianello, L., Scott, M., Cooper, C. M., Wallace, A. C., 94 James, T. L., Cohen, F. E. & Prusiner, S. B. (1997). Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci U S A 94, 10069-74. 101. Sweeting, B., Khan, M. Q., Chakrabartty, A. & Pai, E. F. (2010). Structural factors underlying the species barrier and susceptibility to infection in prion disease. Biochem Cell Biol 88, 195-202. 102. Lysek, D. A., Schorn, C., Nivon, L. G., Esteve-Moya, V., Christen, B., Calzolai, L., von Schroetter, C., Fiorito, F., Herrmann, T., Guntert, P. & Wuthrich, K. (2005). Prion protein NMR structures of cats, dogs, pigs, and sheep. Proc Natl Acad Sci U S A 102, 640-5. 103. Zhang, J. (2011). The structural stability of wild-type horse prion protein. J Biomol Struct Dyn 29, 369-77. 104. Perez, D. R., Damberger, F. F. & Wuthrich, K. (2010). Horse prion protein NMR structure and comparisons with related variants of the mouse prion protein. J Mol Biol 400, 121-8. 105. Saborio, G. P., Permanne, B. & Soto, C. (2001). Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810-3. 106. Fernandez-Borges, N., de Castro, J. & Castilla, J. (2009). In vitro studies of the transmission barrier. Prion 3, 220-3. 107. Vidal, E., Fernandez-Borges, N., Pintado, B., Ordonez, M., Marquez, M., Fondevila, D., Torres, J. M., Pumarola, M. & Castilla, J. (2013). Bovine spongiform encephalopathy induces misfolding of alleged prion-resistant species cellular prion protein without altering its pathobiological features. J Neurosci 33, 7778-86. 108. Jones, E. M. & Surewicz, W. K. (2005). Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell 121, 63-72. 109. Prusiner, S. B., Scott, M., Foster, D., Pan, K. M., Groth, D., Mirenda, C., Torchia, M., Yang, S. L., Serban, D., Carlson, G. A. & et al. (1990). Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63, 673-86. 110. Priola, S. A., Caughey, B., Race, R. E. & Chesebro, B. (1994). Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J Virol 68, 4873-8. 111. Vorberg, I., Groschup, M. H., Pfaff, E. & Priola, S. A. (2003). Multiple amino acid residues within the rabbit prion protein inhibit formation of 95 its abnormal isoform. J Virol 77, 2003-9. 112. Sreerama, N. & Woody, R. W. (2004). Computation and analysis of protein circular dichroism spectra. Methods Enzymol 383, 318-51. 113. Cartoni, C., Schinina, M. E., Maras, B., Nonno, R., Vaccari, G., Di Baria, M. A., Conte, M., Liu, Q. G., Lu, M., Cardone, F., Windl, O., Pocchiari, M. & Agrimi, U. (2005). Identification of the pathological prion protein allotypes in scrapie-infected heterozygous bank voles (Clethrionomys glareolus) by high-performance liquid chromatography-mass spectrometry. J Chromatogr A 1081, 122-6. 114. Takei, T., Okonogi, A., Tateno, K., Kimura, A., Kojima, S., Yazaki, K. & Miura, K. (2006). The effects of the side chains of hydrophobic aliphatic amino acid residues in an amphipathic polypeptide on the formation of alpha helix and its association. J Biochem 139, 271-8. 115. Kim, C. A. & Berg, J. M. (1993). Thermodynamic beta-sheet propensities measured using a zinc-finger host peptide. Nature 362, 267-70. 116. O'Neil, K. T. & DeGrado, W. F. (1990). A thermodynamic scale for the helix-forming tendencies of the commonly occurring amino acids. Science 250, 646-51. 117. Hutchinson, E. G. & Thornton, J. M. (1994). A revised set of potentials for beta-turn formation in proteins. Protein Sci 3, 2207-16. 118. Marsh, R. F. & Bessen, R. A. (1993). Epidemiologic and experimental studies on transmissible mink encephalopathy. Dev Biol Stand 80, 111-8. 119. Piening, N., Nonno, R., Di Bari, M., Walter, S., Windl, O., Agrimi, U., Kretzschmar, H. A. & Bertsch, U. (2006). Conversion efficiency of bank vole prion protein in vitro is determined by residues 155 and 170, but does not correlate with the high susceptibility of bank voles to sheep scrapie in vivo. J Biol Chem 281, 9373-84. 120. Raymond, G. J., Raymond, L. D., Meade-White, K. D., Hughson, A. G., Favara, C., Gardner, D., Williams, E. S., Miller, M. W., Race, R. E. & Caughey, B. (2007). Transmission and adaptation of chronic wasting disease to hamsters and transgenic mice: evidence for strains. J Virol 81, 4305-14. 121. Mathiason, C. K., Nalls, A. V., Seelig, D. M., Kraft, S. L., Carnes, K., Anderson, K. R., Hayes-Klug, J. & Hoover, E. A. (2013). Susceptibility of domestic cats to chronic wasting disease. J Virol 87, 1947-56. 122. Miller, M. W. & Williams, E. S. (2003). Prion disease: horizontal prion transmission in mule deer. Nature 425, 35-6. 123. Weissmann, C., Fischer, M., Raeber, A., Bueler, H., Sailer, A., Shmerling, 96 D., Rulicke, T., Brandner, S. & Aguzzi, A. (1998). The use of transgenic mice in the investigation of transmissible spongiform encephalopathies. Rev Sci Tech 17, 278-90. 124. Miller, M. W., Wild, M. A. & Williams, E. S. (1998). Epidemiology of chronic wasting disease in captive Rocky Mountain elk. J Wildl Dis 34, 532-8. 125. Mathiason, C. K., Hays, S. A., Powers, J., Hayes-Klug, J., Langenberg, J., Dahmes, S. J., Osborn, D. A., Miller, K. V., Warren, R. J., Mason, G. L. & Hoover, E. A. (2009). Infectious prions in pre-clinical deer and transmission of chronic wasting disease solely by environmental exposure. PLoS One 4, e5916. 126. Mathiason, C. K., Powers, J. G., Dahmes, S. J., Osborn, D. A., Miller, K. V., Warren, R. J., Mason, G. L., Hays, S. A., Hayes-Klug, J., Seelig, D. M., Wild, M. A., Wolfe, L. L., Spraker, T. R., Miller, M. W., Sigurdson, C. J., Telling, G. C. & Hoover, E. A. (2006). Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 314, 133-6. 127. Sigurdson, C. J., Williams, E. S., Miller, M. W., Spraker, T. R., O'Rourke, K. I. & Hoover, E. A. (1999). Oral transmission and early lymphoid tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus hemionus). J Gen Virol 80 ( Pt 10), 2757-64. 128. Tamguney, G., Miller, M. W., Wolfe, L. L., Sirochman, T. M., Glidden, D. V., Palmer, C., Lemus, A., DeArmond, S. J. & Prusiner, S. B. (2009). Asymptomatic deer excrete infectious prions in faeces. Nature 461, 529-32. 129. Tamguney, G., Richt, J. A., Hamir, A. N., Greenlee, J. J., Miller, M. W., Wolfe, L. L., Sirochman, T. M., Young, A. J., Glidden, D. V., Johnson, N. L., Giles, K., DeArmond, S. J. & Prusiner, S. B. (2012). Salivary prions in sheep and deer. Prion 6, 52-61. 130. Haley, N. J., Mathiason, C. K., Zabel, M. D., Telling, G. C. & Hoover, E. A. (2009). Detection of sub-clinical CWD infection in conventional test-negative deer long after oral exposure to urine and feces from CWD+ deer. PLoS One 4, e7990. 131. Miller, M. W., Swanson, H. M., Wolfe, L. L., Quartarone, F. G., Huwer, S. L., Southwick, C. H. & Lukacs, P. M. (2008). Lions and prions and deer demise. PLoS One 3, e4019. 132. Heisey, D. M., Mickelsen, N. A., Schneider, J. R., Johnson, C. J., Langenberg, J. A., Bochsler, P. N., Keane, D. P. & Barr, D. J. (2010). Chronic wasting disease (CWD) susceptibility of several North American rodents that are sympatric with cervid CWD epidemics. J Virol 84, 210-5. 97 133. Kurt, T. D., Telling, G. C., Zabel, M. D. & Hoover, E. A. (2009). Trans-species amplification of PrP(CWD) and correlation with rigid loop 170N. Virology 387, 235-43. 134. Conway, K. A., Lee, S. J., Rochet, J. C., Ding, T. T., Williamson, R. E. & Lansbury, P. T., Jr. (2000). Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A 97, 571-6. 135. Conlon, I. J., Dunn, G. A., Mudge, A. W. & Raff, M. C. (2001). Extracellular control of cell size. Nat Cell Biol 3, 918-21. 136. Al-Habori, M. (2001). Macromolecular crowding and its role as intracellular signalling of cell volume regulation. Int J Biochem Cell Biol 33, 844-64. 137. Bhatia, R., Lin, H. & Lal, R. (2000). Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity. FASEB J 14, 1233-43. 138. Nilsberth, C., Westlind-Danielsson, A., Eckman, C. B., Condron, M. M., Axelman, K., Forsell, C., Stenh, C., Luthman, J., Teplow, D. B., Younkin, S. G., Naslund, J. & Lannfelt, L. (2001). The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat Neurosci 4, 887-93. 139. Sousa, M. M., Cardoso, I., Fernandes, R., Guimaraes, A. & Saraiva, M. J. (2001). Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Am J Pathol 159, 1993-2000. 140. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M. & Stefani, M. (2002). Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-11. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/6102 | - |
dc.description.abstract | 傳播性海綿樣腦病是一種致死性的神經退化疾病會影響許多哺乳類動物,造成此病的原因是由非傳統性的感染病原普立昂(prion)所引起。Prion的傳播在同物種間比較容易發生,然而在不同物種之間則受限於「種族屏障」,也就是當外來的普立昂胺基酸序列若是與宿主的胺基酸序列相似度差異大的話就會影響對prion的形成並且不容易跨種傳染。為研究普立昂感染屏障與胺基酸序列的關係,我們截取普遍認為普立昂蛋白最重要的一段胺基酸序列108-144為模型,合成數條普立昂胜肽比較其類澱粉形成的特性,此外更利用晶種滴定方法量化出不同物種間普立昂疾病的感染屏障並檢測不同之胺基酸序列如何影響感染效率。
實驗結果顯示,PrP第112號殘基若為甲硫胺酸,會促進類澱粉纖維形成時的成核作用,若第139號殘基是甲硫胺酸、第143號殘基為絲胺酸則會延遲成核作用,但若同一條胜肽存在上述條件時,類澱粉纖維形成的效果會被中和。此外,若是以已經形成類澱粉纖維的牛(bPrP)為晶種進行引晶實驗會發現,第129號殘基若是白胺酸、第135號殘基為天門冬胺酸、第139號殘基是甲硫胺酸、第143號殘基為絲胺酸皆會使引晶屏障變高,但若138號殘基為甲硫胺酸則會降低引晶屏障,若是增加引晶屏障與降低引晶屏障兩者影響因子同時出現在一條普立昂胜肽上,則兩者的影響會相互抵銷。整體而言,bPrP對於catPrP、mPrP與bvPrP屬於低度引晶屏障,對於huPrP、haPrP與lionPrP則屬於中度引晶屏障,而對於mdPrP、dogPrP與pigPrP屬於高度引晶屏障。 若是以已經形成類澱粉纖維的北美大角鹿(mdPrP)為晶種進行引晶實驗,對bvPrP來說屬於低度種族屏障,而對於catPrP、lionPrP與mPrP則屬於中度引晶屏障,而對於bPrP、pigPrP、dogPrP、haPrP以及huPrP則屬於高度引晶屏障。 | zh_TW |
dc.description.abstract | Transmissible spongiform encephalopathies (TSE) are a group of fatal neurodegenerative diseases of mammals, caused by unconventional infectious agents known as “prion”. Transmission of prion between species is limited by a so called “species barrier”. Prion formation could be affected dramatically if the amino acid sequences between the host PrPC (cellular prion protein) and the inoculated prion are different, which results in the resistance of cross-species TSE transmission. In order to explore the correlation between the prion transmission barrier and the amino acid sequence, several prion peptides (sequences 108-144) were synthesized(the sequence 108-144 based on the numbering of human prion protein sequence) and the amyloidogenic properties of these peptides were compared. We used seeding titration method to quantify the seeding barrier and to examine how sequence difference affected the seeding efficiency. Our results showed that while residue 112 with methionine accelerated nucleation, residues 139 with methionine or 143 with serine retarded the nucleation process. But these effects could be neutralized when the substitutions with opposite effects had shown on the same peptide. Moreover, using the amyloid fibrils prepared from bPrP as seed, residues 129 with leucine, 135 with asparagine, 139 with methionine or 143 with serine substitution could increase seeding barrier, but residue 138 with methionine decreased seeding barrier. When both decreased and increased factors were appeared in the same peptide, their effects tended to cancel each other out. Overall, the relative seeding barrier is low for catPrP, mPrP, and bvPrP; moderate for huPrP, haPrP, and lionPrP; high for mdPrP, dogPrP, and pigPrP.
When the amyloid fibrils prepared from mdPrP were used as seed, the relative seeding barriers for all these peptides were different from the bPrP seeding results: the relative seeding barrier is low for bvPrP; moderate for catPrP, lionPrP, and mPrP; high for bPrP, pigPrP, dogPrP, haPrP, and huPrP. | en |
dc.description.provenance | Made available in DSpace on 2021-05-16T16:20:56Z (GMT). No. of bitstreams: 1 ntu-102-D93b46010-1.pdf: 6936111 bytes, checksum: 1682b75711b6adfe157ef1d8d5d78b7f (MD5) Previous issue date: 2013 | en |
dc.description.tableofcontents | 摘要 .....................................................................................................................................I
Abstract........................................................................................................................ II 目錄....................................................................................................................................IV 圖目錄..........................................................................................................................VI 表目錄.......................................................................................................................VIII 縮寫表 Abbreviations................................................................................................IX 1.1 蛋白質錯誤折疊與普立昂疾病...................................................................1 1.2 單一蛋白學說(protein only hypothesis)..................................................6 1.3 普立昂蛋白結構............................................................................................7 1.4 類澱粉纖維的形成......................................................................................11 1.5 普立昂蛋白之構形轉變..............................................................................14 1.6 普立昂之跨物種傳染..................................................................................15 1.6.1 小鼠與敘利亞倉鼠間的種族屏障...................................................17 1.6.2 人類與牛之間的種族屏障...............................................................19 1.6.3 人類與鹿之間的種族屏障...............................................................20 1.7 其他物種之種族屏障的研究.....................................................................22 1.8 其他普立昂種族屏障的相關研究.............................................................22 1.9 本論文動機.................................................................................................23 第二章 材料與方法..................................................................................................25 2.1 材料.............................................................................................................25 2.1.1 水......................................................................................................25 2.1.2 化學藥品...........................................................................................25 2.2 儀器..............................................................................................................27 V 2.2.1 純化、分析用管柱...........................................................................27 2.2.2 大型儀器...........................................................................................27 2.3 方法.............................................................................................................28 2.3.1 普立昂胜肽的合成、純化與鑑定..................................................28 2.3.2 以圓二色光譜紀錄普立昂胜肽之類澱粉纖維形成.......................36 2.3.3 以高效液相層析儀進行熱力學溶解度的分析...............................42 2.3.4 以穿透式電子顯微鏡觀測普立昂蛋白類澱粉纖維織形態..........42 2.3.5 細胞存活檢測(MTT cell viability assay) ..................................43 第三章 結果與討論..................................................................................................45 3. 1 胺基酸殘基在類澱粉纖維形成中所扮演的重要角色............................45 3.2 物種間種族屏障及普立昂疾病跨種傳染的評估.....................................54 3.2.1 引晶對類澱粉纖維形成的影響......................................................54 3.2.2 觀察牛(bPrP)與不同物種間之種族屏障..................................55 3.3 胺基酸的結構、化學特性與位置對普立昂胜肽的影響.........................59 3.3.1 將Met 置換成Val 或Leu...............................................................59 3.3.2 將Val、Leu 或Ile 置換成Met ......................................................60 3.3.3 Ser 與Asn 互相置換.......................................................................61 3.4 普立昂胜肽的熱力學溶解度(thermodynamic solubility)觀察...........63 3.5 普立昂胜肽形成之類澱粉纖維型態.........................................................65 3.5.1 以穿透式電子顯微鏡觀測各物種普立昂胜肽片段序列108-144 .66 類澱粉纖維之形態............................................................................66 3.6 觀察北美大角鹿(mdPrP)與不同物種間之種族屏障..........................72 3.7 類澱粉纖維的前驅物(precursor)對細胞毒性的影響.........................77 第四章 結果與討論..................................................................................................82 參考文獻......................................................................................................................86 附錄 …………………………………………………………………………………98 | |
dc.language.iso | zh-TW | |
dc.title | 研究普立昂感染屏障與胺基酸序列的關係 | zh_TW |
dc.title | Exploring the relationship of prion transmission barrier
and amino acid sequence | en |
dc.type | Thesis | |
dc.date.schoolyear | 101-2 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 王勝仕,徐駿森,黃人則,李政怡 | |
dc.subject.keyword | 普立昂,類澱粉纖維,引晶,種族屏障,胺基酸序列, | zh_TW |
dc.subject.keyword | Prion,amyloid fiber,seeding,species barrier,amino acid sequence, | en |
dc.relation.page | 107 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2013-08-01 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 生化科學研究所 | zh_TW |
顯示於系所單位: | 生化科學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-102-1.pdf | 6.77 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。